Buthionine Sulphoximine - CAS 5072-26-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C8H18N2O3S
Molecular Weight:
222.3
COA:
Inquire
Targets:
Others
Description:
Buthionine Sulphoximine, also known as NSC-326231, is a potent and specific inhibitor of alpha-glutamyl cysteine synthetase.
Appearance:
Solid powder
Synonyms:
2-amino-4-(butylsulfonimidoyl)butanoic acid; NSC-326231; BSO; Buthionine Sulphoximine; DL-Buthionine-(S,R)-sulfoximine.
Storage:
Store in a cool and dry place (or refer to the Certificate of Analysis).
MSDS:
Inquire
Boiling Point:
382.3±52.0 °C at 760 Torr
Density:
1.29±0.1 g/cm3
InChIKey:
KJQFBVYMGADDTQ-UHFFFAOYSA-N
InChI:
1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12)
Canonical SMILES:
N[C@@H](CCS(CCCC)(=O)=N)C(O)=O
1.The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.
Rodríguez-Gómez I;Carmona-Cortés J;Wangensteen R;Vargas-Tendero P;Banegas I;Quesada A;García-Lora AM;Vargas F Tumour Biol. 2014 Aug;35(8):7799-805. doi: 10.1007/s13277-014-2046-2. Epub 2014 May 11.
This study evaluated the effects of the pro-oxidant buthionine sulfoximine (BSO) and of the interaction between BSO and TETRAC, an antagonist of αvß3 integrin, on tumor development and aminopeptidase (AP) activity in a murine model of implanted Lewis's carcinoma. Male CBA-C57 mice were untreated (controls) or treated with BSO (222 mg/100 mL in drinking water), TETRAC (10 mg/kg/day, i.p.), or BSO + TETRAC. BSO for 28 days and TETRAC were given for the last 20 days. Mice were subcutaneously inoculated with 1 × 10(6) Lewis carcinoma 3LL cells into the dorsum. Study variables were tumor weight (TW); Hb, as index of tumor-mediated angiogenesis; vascular endothelial growth factor (VEGF) protein abundance; protein carbonyl content; α-tubulin abundance; and GluAp, AlaAp, and AspAp activities. BSO produced a major decrease in TW (203 ± 18 mg) with respect to controls (365 ± 26) and a reduction in Hb content. The TETRAC group also showed marked reductions in TW (129 ± 15) and Hb concentration associated with a reduced VEGF content. The BSO + TETRAC group showed a major TW reduction (125 ± 13); although, the difference with the TETRAC group was not significant. BSO treatment increased protein carbonyl and tubulin abundance in comparison to controls.
2.Aqueous extract of Trigonella foenum-graecum L. ameliorates additive urotoxicity of buthionine sulfoximine and cyclophosphamide in mice.
Bhatia K;Kaur M;Atif F;Ali M;Rehman H;Rahman S;Raisuddin S Food Chem Toxicol. 2006 Oct;44(10):1744-50. Epub 2006 Jun 3.
Cyclophosphamide (CP) is a commonly used anti-cancer drug which causes toxicity by its reactive metabolites such as acrolein and phosphoramide mustard. In the present study modulation of toxicity caused by concomitant exposure to CP and l-buthionine-SR-sulfoximine (BSO) by fenugreek (Trigonella foenum-graecum L.) extract was evaluated by measuring lipid peroxidation (LPO) and anti-oxidants in urinary bladder in mice. Fenugreek, a common dietary and medicinal herb, showed protective effect not only on LPO but also on the enzymatic anti-oxidants. CP-treated animals exhibited a significant decrease in the activities of glutathione S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GP) and catalase (CAT) when compared to the controls. Level of reduced glutathione (GSH) was also reduced with an increase in LPO in CP-treated animals. BSO treatment depicted an additive toxic effect in CP-treated animals. Pre-treatment of herbal extract restored activities of all the enzymes and thus showed an overall protective effect on additive effect of CP and BSO. Restoration of GSH by extract treatment may play an important role in reversing CP-induced apoptosis and free radical-mediated LPO in urinary bladder.
3.Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC;Denekamp J;Minchinton AI Radiat Res. 1985 Jun;102(3):283-94.
Buthionine sulfoximine (BSO) has been used to deplete glutathione (GSH) in V79-379A cells in vitro, and the effect on the efficiency of oxygen and misonidazole (MISO) as radiosensitizers has been determined. Treatment with 50 or 500 microM BSO caused a rapid decline in GSH content to less than 5% of control values after 10 hr of exposure (t1/2 = 1.6 hr). Removal of BSO resulted in a rapid regeneration of GSH after 50 microM BSO, but little regeneration was observed over the subsequent 10-hr period after 500 microM. Treatment with either of these two concentrations of BSO for up to 14 hr did not affect cell growth or viability. Cells irradiated in monolayer on glass had an oxygen enhancement ratio (OER) of 3.1. After 10-14 hr pretreatment with 50 microM BSO, washed cells were radiosensitized by GSH depletion at all oxygen tensions tested. The OER was reduced to 2.6, due to greater radiosensitization of hypoxic cells than aerated ones by GSH depletion. GSH depletion had the effect of shifting the enhancement ratio vs pO2 curve to lower oxygen tensions, making oxygen appear more efficient by a factor of approximately 2, based on the pO2 required to give an OER of 2.0. In similar experiments performed with MISO, an enhancement ratio of 2.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 1416992-39-6 GC376 sodium

GC376 sodium
(CAS: 1416992-39-6)

GC376 is a 3CLpro inhibitor which is previously reported to be active against the 3CLpro of multiple coronaviruses, including SARS-CoV, but with highest potency...

CAS 464-49-3 D(+)-Camphor

D(+)-Camphor
(CAS: 464-49-3)

(R)-(+)-Camphor is a terpenoid used as a culinary flavouring agent in parts of asia.

CAS 34576-94-8 BT2

BT2
(CAS: 34576-94-8)

BT2 is an allosteric inhibitor of branched-chain α-ketoacid dehydrogenase (BCKDC) kinase (BDK; IC50 = 3.19 μM). BT2 can dissociate BDK from BCKDC via binding to...

CAS 1215333-48-4 GR 144053 trihydrochloride

GR 144053 trihydrochloride
(CAS: 1215333-48-4)

GR 144053 trihydrochloride is a potent and selective orally bioactive platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist (IC50 = 37 nM)....

CAS 16980-89-5 Bucladesine sodium salt

Bucladesine sodium salt
(CAS: 16980-89-5)

Bucladesine is a cell-permeable, cyclic nucleotide derivative that mimics the action of endogenous cyclic adenosine monophosphate (cAMP) and is a phosphodiester...

CAS 1228445-38-2 Pyrintegrin

Pyrintegrin
(CAS: 1228445-38-2)

Pyrintegrin, a 2,4-disubstituted pyrimidine, enhances survival of human embryonic stem cells (hESCs) following enzymatic dissociation. Pyrintegrin increases the...

BPH-652
(CAS: 157124-84-0)

BPH-652, also known as BMS-187745, has been found to be a SQS inhibitor that could probably be effective against S. aureus infections.

CAS 2901-75-9 N-Acetyl-DL-phenylalanine

N-Acetyl-DL-phenylalanine
(CAS: 2901-75-9)

N-Acetyl-DL-phenylalanine is a drug to treat depression.

HLCL65 hydrochloride

HLCL65 hydrochloride is a first-in-class inhibitor of PRMT5. HLCL65 selectively inhibits Th1 cell proliferation (IC50 value 1.1 μM). In vivo, HLCL65 suppresses ...

LY 181984
(CAS: 3955-50-8)

LY 181984 is an antitumor sulfonylurea.

CAS 346640-08-2 CCF-642

CCF-642
(CAS: 346640-08-2)

CCF-642 is a protein disulfide isomerase (PDI) inhibitor that exhibits 100-fold higher potency than PACMA 31 (by di-E-GSSG assay) via an alternative mode of act...

CAS 1046045-61-7 FGH10019

FGH10019
(CAS: 1046045-61-7)

FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM, 5-10 times lower than the IC50 of fatostatin (~10 μM).

CAS 1161-94-0 Phenamil

Phenamil
(CAS: 1161-94-0)

Phenamil, a second generation analog of amiloride (hydrochloride), inhibits TRPP3-mediated currents (IC50 = 0.14 μM) and also inhibits epithelial Na+ channels (...

CAS 257292-29-8 KF 38789

KF 38789
(CAS: 257292-29-8)

KF 38789 is a selective inhibitor of P-selectin-mediated cell adhesion with IC50 value of 1.97 μM. It shows no effects on E-selectin-mediated and L-selectin- ad...

CAS 135-16-0 L-Tetrahydrofolic Acid

L-Tetrahydrofolic Acid
(CAS: 135-16-0)

Tetrahydrofolic acid is a folic acid derivative. It is a cofactor in many bio-reactions, especially in the metabolism of amino acids and nucleic acids.

CAS 680590-49-2 EMPA

EMPA
(CAS: 680590-49-2)

EMPA is a potent and selective OX2 receptor antagonist (IC50 = 2.3 nM and 1900 nM for OX2 and OX1, respectively) with no activity at a panel of 80 receptors. EM...

CAS 213400-34-1 UPF-648

UPF-648
(CAS: 213400-34-1)

Potent and selective inhibitor of kynurenine-3-monooxygenase (KMO, or kynurenine hydroxylase) activity (IC50: 20 nM); Active (+)-(1S,2S)-enantiomer; Useful tool...

CAS 25487-28-9 Talsupram hydrochloride

Talsupram hydrochloride
(CAS: 25487-28-9)

Talsupram hydrochloride is a selective noradrenalin reuptake (SLC6A2) inhibitor, displaying high affinity for the human noradrenalin transporter (NET) against S...

CAS 59-67-6 Nicotinic Acid

Nicotinic Acid
(CAS: 59-67-6)

Nicotinic Acid is a water-soluble vitamin belonging to the vitamin B family.

CAS 1264-62-6 Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate
(CAS: 1264-62-6)

Erythromycin Ethylsuccinate, an oral macrolide antibiotic produced by Streptomyces erythreus, reversibly binds to the 50S ribosome of bacteria, and inhibits pro...

Chemical Structure

CAS 5072-26-4 Buthionine Sulphoximine

Quick Inquiry

Verification code

Featured Items